Company / Operating Income per Share
ABEONA THERAPEUTICS INC. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.96
FY2025
5-year range
-$15.26 / -$0.85
FY2021-FY2025
Trend
-10.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has fluctuated over the past 10 years, ranging from $-15.26 in FY2022 to $-0.58 in FY2019.
Based on SEC 10-K filings.
-1.96 in FY2025.
Improved from $-2.87 to $-1.96 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share decreased 10.3% year-over-year.
- Peak operating income per share was recorded in FY2019.
- Lowest operating income per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -2.42 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.96 | -10.3% |
| FY2024 | -$1.78 | +38.2% |
| FY2023 | -$2.87 | +81.2% |
| FY2022 | -$15.26 | -1701.4% |
| FY2021 | -$0.85 | +8.1% |
| FY2020 | -$0.92 | -58.8% |
| FY2019 | -$0.58 | +53.2% |
| FY2018 | -$1.24 | -79.4% |
| FY2017 | -$0.69 | -2.9% |
| FY2016 | -$0.67 | +58.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026